Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer
Anticancer Research · 2024
DOI: 10.21873/anticanres.17114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Ikuma Shioi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Capecitabine, Oxaliplatin, Antineoplastic Combined Chemotherapy Protocols.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
- Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan hiroomio@gmail.com.
Zitieren
APA
Shioi, I., Ogawa, H., Naito, R., Endo, M., Hosoi, N., Tateno, K., Uchida, S., Yamaguchi, A., Watanabe, T., Nakazawa, N., Shibasaki, Y., Komine, C., Shiraishi, T., Osone, K., Okada, T., Sano, A., Sakai, M., Sohda, M., Shirabe, K., & Saeki, H. (2024). Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17114
Vancouver
Shioi I, Ogawa H, Naito R, Endo M, Hosoi N, Tateno K, et al. Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.17114
BibTeX
@article{Shioi2024,
author = {Shioi, Ikuma and Ogawa, Hiroomi and Naito, Ryozan and Endo, Mizuki and Hosoi, Nobuhiro and Tateno, Kohei and Uchida, Shintaro and Yamaguchi, Arisa and Watanabe, Takayoshi and Nakazawa, Nobuhiro and Shibasaki, Yuta and Komine, Chika and Shiraishi, Takuya and Osone, Katsuya and Okada, Takuhisa and Sano, Akihiko and Sakai, Makoto and Sohda, Makoto and Shirabe, Ken and Saeki, Hiroshi},
title = {Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17114}
}
EUVIMED